Global Volatile Anaesthetic Agents Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Volatile Anaesthetic Agents market size was valued at US$ 1086 million in 2025 and is forecast to a readjusted size of US$ 1407 million by 2032 with a CAGR of 3.8% during review period.
Volatile Anaesthetic Agents are volatile liquids or gases that are breathed in through the lungs to produce and maintain general anaesthesia, causing a controlled, reversible state of unconsciousness along with reduced pain perception, amnesia, and suppression of movement and reflexes during surgery or procedures. They are delivered via an anaesthesia machine and vaporizer (for volatile liquids) or as a medical gas, mixed with oxygen or air and titrated in real time by adjusting the inspired concentration; their clinical effect depends largely on how they move from the lungs into the bloodstream and then the brain, which is influenced by factors like blood?gas solubility (speed of onset and recovery), ventilation, and cardiac output. Common examples include sevoflurane, isoflurane, desflurane, and nitrous oxide, chosen based on desired speed, haemodynamic stability, airway tolerance, and patient factors; while generally safe under monitoring, they can cause side effects such as low blood pressure, respiratory depression, postoperative nausea and vomiting, and?rarely?malignant hyperthermia in susceptible individuals. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.
Upstream for Volatile Anaesthetic Agents begins with basic petrochemical feedstocks that are converted into highly fluorinated/halogenated intermediates using specialty reagents (notably fluorinating and chlorinating agents), catalysts, and tightly controlled reaction and purification steps, because these products must meet very high purity and stability requirements under pharmaceutical GMP; manufacturers then distill and dry the anesthetic to specification, perform rigorous QC (impurities, water content, identity), and fill it into dedicated, moisture-tight bottles/canisters with compliant labeling and cold-chain-free but controlled logistics. Downstream, finished product moves through pharma wholesalers and hospital procurement channels to operating rooms and ambulatory surgery centers, where it is used with anesthesia machines and calibrated vaporizers (plus carrier gases) and supported by consumables and infrastructure such as breathing circuits, CO? absorbents, and waste-gas scavenging systems; used anesthetic largely leaves the patient via exhalation and is routed into scavenging/disposal pathways (increasingly with capture/destruction or monitoring in some facilities), while ongoing demand is driven by surgical volumes, formulary choices, and workplace exposure and environmental management practices.
This report is a detailed and comprehensive analysis for global Volatile Anaesthetic Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Volatile Anaesthetic Agents market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Volatile Anaesthetic Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Volatile Anaesthetic Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Volatile Anaesthetic Agents market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Volatile Anaesthetic Agents market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Volatile Anaesthetic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Volatile Anaesthetic Agents, with price, sales quantity, revenue, and global market share of Volatile Anaesthetic Agents from 2021 to 2026.
Chapter 3, the Volatile Anaesthetic Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Volatile Anaesthetic Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Volatile Anaesthetic Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Volatile Anaesthetic Agents.
Chapter 14 and 15, to describe Volatile Anaesthetic Agents sales channel, distributors, customers, research findings and conclusion.
Volatile Anaesthetic Agents are volatile liquids or gases that are breathed in through the lungs to produce and maintain general anaesthesia, causing a controlled, reversible state of unconsciousness along with reduced pain perception, amnesia, and suppression of movement and reflexes during surgery or procedures. They are delivered via an anaesthesia machine and vaporizer (for volatile liquids) or as a medical gas, mixed with oxygen or air and titrated in real time by adjusting the inspired concentration; their clinical effect depends largely on how they move from the lungs into the bloodstream and then the brain, which is influenced by factors like blood?gas solubility (speed of onset and recovery), ventilation, and cardiac output. Common examples include sevoflurane, isoflurane, desflurane, and nitrous oxide, chosen based on desired speed, haemodynamic stability, airway tolerance, and patient factors; while generally safe under monitoring, they can cause side effects such as low blood pressure, respiratory depression, postoperative nausea and vomiting, and?rarely?malignant hyperthermia in susceptible individuals. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.
Upstream for Volatile Anaesthetic Agents begins with basic petrochemical feedstocks that are converted into highly fluorinated/halogenated intermediates using specialty reagents (notably fluorinating and chlorinating agents), catalysts, and tightly controlled reaction and purification steps, because these products must meet very high purity and stability requirements under pharmaceutical GMP; manufacturers then distill and dry the anesthetic to specification, perform rigorous QC (impurities, water content, identity), and fill it into dedicated, moisture-tight bottles/canisters with compliant labeling and cold-chain-free but controlled logistics. Downstream, finished product moves through pharma wholesalers and hospital procurement channels to operating rooms and ambulatory surgery centers, where it is used with anesthesia machines and calibrated vaporizers (plus carrier gases) and supported by consumables and infrastructure such as breathing circuits, CO? absorbents, and waste-gas scavenging systems; used anesthetic largely leaves the patient via exhalation and is routed into scavenging/disposal pathways (increasingly with capture/destruction or monitoring in some facilities), while ongoing demand is driven by surgical volumes, formulary choices, and workplace exposure and environmental management practices.
This report is a detailed and comprehensive analysis for global Volatile Anaesthetic Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Volatile Anaesthetic Agents market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Volatile Anaesthetic Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Volatile Anaesthetic Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Volatile Anaesthetic Agents market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Volatile Anaesthetic Agents
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Volatile Anaesthetic Agents market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Heptafluoroane
- Desflurane
- Isoflurane
- Others
- Below 3%
- Above 3%
- Human Use
- Animal Use
- Baxter
- AbbVie
- Piramal Critical Care
- Fresenius Kabi
- Halocarbon
- Aspen
- Pfizer
- Maruishi Pharmaceutical
- Jiangsu Hengrui Medicine
- Lunan Pharmaceutical
- Hikma Pharmaceuticals
- HeBei YiPin Pharmaceutical
- Dechra Pharmaceuticals
- Life Sciences
- Zhejiang AngLiKang Pharmaceutical
- Linde Healthcare
- Air Liquide
- Messer
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Volatile Anaesthetic Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Volatile Anaesthetic Agents, with price, sales quantity, revenue, and global market share of Volatile Anaesthetic Agents from 2021 to 2026.
Chapter 3, the Volatile Anaesthetic Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Volatile Anaesthetic Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Volatile Anaesthetic Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Volatile Anaesthetic Agents.
Chapter 14 and 15, to describe Volatile Anaesthetic Agents sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Volatile Anaesthetic Agents Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Heptafluoroane
1.3.3 Desflurane
1.3.4 Isoflurane
1.3.5 Others
1.4 Market Analysis by MAC
1.4.1 Overview: Global Volatile Anaesthetic Agents Consumption Value by MAC: 2021 Versus 2025 Versus 2032
1.4.2 Below 3%
1.4.3 Above 3%
1.5 Market Analysis by Application
1.5.1 Overview: Global Volatile Anaesthetic Agents Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Human Use
1.5.3 Animal Use
1.6 Global Volatile Anaesthetic Agents Market Size & Forecast
1.6.1 Global Volatile Anaesthetic Agents Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Volatile Anaesthetic Agents Sales Quantity (2021-2032)
1.6.3 Global Volatile Anaesthetic Agents Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Volatile Anaesthetic Agents Product and Services
2.1.4 Baxter Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Baxter Recent Developments/Updates
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Volatile Anaesthetic Agents Product and Services
2.2.4 AbbVie Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 AbbVie Recent Developments/Updates
2.3 Piramal Critical Care
2.3.1 Piramal Critical Care Details
2.3.2 Piramal Critical Care Major Business
2.3.3 Piramal Critical Care Volatile Anaesthetic Agents Product and Services
2.3.4 Piramal Critical Care Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Piramal Critical Care Recent Developments/Updates
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business
2.4.3 Fresenius Kabi Volatile Anaesthetic Agents Product and Services
2.4.4 Fresenius Kabi Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Fresenius Kabi Recent Developments/Updates
2.5 Halocarbon
2.5.1 Halocarbon Details
2.5.2 Halocarbon Major Business
2.5.3 Halocarbon Volatile Anaesthetic Agents Product and Services
2.5.4 Halocarbon Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Halocarbon Recent Developments/Updates
2.6 Aspen
2.6.1 Aspen Details
2.6.2 Aspen Major Business
2.6.3 Aspen Volatile Anaesthetic Agents Product and Services
2.6.4 Aspen Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Aspen Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Volatile Anaesthetic Agents Product and Services
2.7.4 Pfizer Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Pfizer Recent Developments/Updates
2.8 Maruishi Pharmaceutical
2.8.1 Maruishi Pharmaceutical Details
2.8.2 Maruishi Pharmaceutical Major Business
2.8.3 Maruishi Pharmaceutical Volatile Anaesthetic Agents Product and Services
2.8.4 Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Maruishi Pharmaceutical Recent Developments/Updates
2.9 Jiangsu Hengrui Medicine
2.9.1 Jiangsu Hengrui Medicine Details
2.9.2 Jiangsu Hengrui Medicine Major Business
2.9.3 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product and Services
2.9.4 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.10 Lunan Pharmaceutical
2.10.1 Lunan Pharmaceutical Details
2.10.2 Lunan Pharmaceutical Major Business
2.10.3 Lunan Pharmaceutical Volatile Anaesthetic Agents Product and Services
2.10.4 Lunan Pharmaceutical Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Lunan Pharmaceutical Recent Developments/Updates
2.11 Hikma Pharmaceuticals
2.11.1 Hikma Pharmaceuticals Details
2.11.2 Hikma Pharmaceuticals Major Business
2.11.3 Hikma Pharmaceuticals Volatile Anaesthetic Agents Product and Services
2.11.4 Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hikma Pharmaceuticals Recent Developments/Updates
2.12 HeBei YiPin Pharmaceutical
2.12.1 HeBei YiPin Pharmaceutical Details
2.12.2 HeBei YiPin Pharmaceutical Major Business
2.12.3 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product and Services
2.12.4 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 HeBei YiPin Pharmaceutical Recent Developments/Updates
2.13 Dechra Pharmaceuticals
2.13.1 Dechra Pharmaceuticals Details
2.13.2 Dechra Pharmaceuticals Major Business
2.13.3 Dechra Pharmaceuticals Volatile Anaesthetic Agents Product and Services
2.13.4 Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Dechra Pharmaceuticals Recent Developments/Updates
2.14 Life Sciences
2.14.1 Life Sciences Details
2.14.2 Life Sciences Major Business
2.14.3 Life Sciences Volatile Anaesthetic Agents Product and Services
2.14.4 Life Sciences Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Life Sciences Recent Developments/Updates
2.15 Zhejiang AngLiKang Pharmaceutical
2.15.1 Zhejiang AngLiKang Pharmaceutical Details
2.15.2 Zhejiang AngLiKang Pharmaceutical Major Business
2.15.3 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product and Services
2.15.4 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
2.16 Linde Healthcare
2.16.1 Linde Healthcare Details
2.16.2 Linde Healthcare Major Business
2.16.3 Linde Healthcare Volatile Anaesthetic Agents Product and Services
2.16.4 Linde Healthcare Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Linde Healthcare Recent Developments/Updates
2.17 Air Liquide
2.17.1 Air Liquide Details
2.17.2 Air Liquide Major Business
2.17.3 Air Liquide Volatile Anaesthetic Agents Product and Services
2.17.4 Air Liquide Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Air Liquide Recent Developments/Updates
2.18 Messer
2.18.1 Messer Details
2.18.2 Messer Major Business
2.18.3 Messer Volatile Anaesthetic Agents Product and Services
2.18.4 Messer Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Messer Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VOLATILE ANAESTHETIC AGENTS BY MANUFACTURER
3.1 Global Volatile Anaesthetic Agents Sales Quantity by Manufacturer (2021-2026)
3.2 Global Volatile Anaesthetic Agents Revenue by Manufacturer (2021-2026)
3.3 Global Volatile Anaesthetic Agents Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Volatile Anaesthetic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Volatile Anaesthetic Agents Manufacturer Market Share in 2025
3.4.3 Top 6 Volatile Anaesthetic Agents Manufacturer Market Share in 2025
3.5 Volatile Anaesthetic Agents Market: Overall Company Footprint Analysis
3.5.1 Volatile Anaesthetic Agents Market: Region Footprint
3.5.2 Volatile Anaesthetic Agents Market: Company Product Type Footprint
3.5.3 Volatile Anaesthetic Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Volatile Anaesthetic Agents Market Size by Region
4.1.1 Global Volatile Anaesthetic Agents Sales Quantity by Region (2021-2032)
4.1.2 Global Volatile Anaesthetic Agents Consumption Value by Region (2021-2032)
4.1.3 Global Volatile Anaesthetic Agents Average Price by Region (2021-2032)
4.2 North America Volatile Anaesthetic Agents Consumption Value (2021-2032)
4.3 Europe Volatile Anaesthetic Agents Consumption Value (2021-2032)
4.4 Asia-Pacific Volatile Anaesthetic Agents Consumption Value (2021-2032)
4.5 South America Volatile Anaesthetic Agents Consumption Value (2021-2032)
4.6 Middle East & Africa Volatile Anaesthetic Agents Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
5.2 Global Volatile Anaesthetic Agents Consumption Value by Type (2021-2032)
5.3 Global Volatile Anaesthetic Agents Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
6.2 Global Volatile Anaesthetic Agents Consumption Value by Application (2021-2032)
6.3 Global Volatile Anaesthetic Agents Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
7.2 North America Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
7.3 North America Volatile Anaesthetic Agents Market Size by Country
7.3.1 North America Volatile Anaesthetic Agents Sales Quantity by Country (2021-2032)
7.3.2 North America Volatile Anaesthetic Agents Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
8.2 Europe Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
8.3 Europe Volatile Anaesthetic Agents Market Size by Country
8.3.1 Europe Volatile Anaesthetic Agents Sales Quantity by Country (2021-2032)
8.3.2 Europe Volatile Anaesthetic Agents Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Volatile Anaesthetic Agents Market Size by Region
9.3.1 Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Volatile Anaesthetic Agents Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
10.2 South America Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
10.3 South America Volatile Anaesthetic Agents Market Size by Country
10.3.1 South America Volatile Anaesthetic Agents Sales Quantity by Country (2021-2032)
10.3.2 South America Volatile Anaesthetic Agents Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Volatile Anaesthetic Agents Market Size by Country
11.3.1 Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Volatile Anaesthetic Agents Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Volatile Anaesthetic Agents Market Drivers
12.2 Volatile Anaesthetic Agents Market Restraints
12.3 Volatile Anaesthetic Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Volatile Anaesthetic Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Volatile Anaesthetic Agents
13.3 Volatile Anaesthetic Agents Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Volatile Anaesthetic Agents Typical Distributors
14.3 Volatile Anaesthetic Agents Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Volatile Anaesthetic Agents Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Heptafluoroane
1.3.3 Desflurane
1.3.4 Isoflurane
1.3.5 Others
1.4 Market Analysis by MAC
1.4.1 Overview: Global Volatile Anaesthetic Agents Consumption Value by MAC: 2021 Versus 2025 Versus 2032
1.4.2 Below 3%
1.4.3 Above 3%
1.5 Market Analysis by Application
1.5.1 Overview: Global Volatile Anaesthetic Agents Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Human Use
1.5.3 Animal Use
1.6 Global Volatile Anaesthetic Agents Market Size & Forecast
1.6.1 Global Volatile Anaesthetic Agents Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Volatile Anaesthetic Agents Sales Quantity (2021-2032)
1.6.3 Global Volatile Anaesthetic Agents Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Volatile Anaesthetic Agents Product and Services
2.1.4 Baxter Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Baxter Recent Developments/Updates
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Volatile Anaesthetic Agents Product and Services
2.2.4 AbbVie Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 AbbVie Recent Developments/Updates
2.3 Piramal Critical Care
2.3.1 Piramal Critical Care Details
2.3.2 Piramal Critical Care Major Business
2.3.3 Piramal Critical Care Volatile Anaesthetic Agents Product and Services
2.3.4 Piramal Critical Care Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Piramal Critical Care Recent Developments/Updates
2.4 Fresenius Kabi
2.4.1 Fresenius Kabi Details
2.4.2 Fresenius Kabi Major Business
2.4.3 Fresenius Kabi Volatile Anaesthetic Agents Product and Services
2.4.4 Fresenius Kabi Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Fresenius Kabi Recent Developments/Updates
2.5 Halocarbon
2.5.1 Halocarbon Details
2.5.2 Halocarbon Major Business
2.5.3 Halocarbon Volatile Anaesthetic Agents Product and Services
2.5.4 Halocarbon Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Halocarbon Recent Developments/Updates
2.6 Aspen
2.6.1 Aspen Details
2.6.2 Aspen Major Business
2.6.3 Aspen Volatile Anaesthetic Agents Product and Services
2.6.4 Aspen Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Aspen Recent Developments/Updates
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Volatile Anaesthetic Agents Product and Services
2.7.4 Pfizer Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Pfizer Recent Developments/Updates
2.8 Maruishi Pharmaceutical
2.8.1 Maruishi Pharmaceutical Details
2.8.2 Maruishi Pharmaceutical Major Business
2.8.3 Maruishi Pharmaceutical Volatile Anaesthetic Agents Product and Services
2.8.4 Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Maruishi Pharmaceutical Recent Developments/Updates
2.9 Jiangsu Hengrui Medicine
2.9.1 Jiangsu Hengrui Medicine Details
2.9.2 Jiangsu Hengrui Medicine Major Business
2.9.3 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product and Services
2.9.4 Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates
2.10 Lunan Pharmaceutical
2.10.1 Lunan Pharmaceutical Details
2.10.2 Lunan Pharmaceutical Major Business
2.10.3 Lunan Pharmaceutical Volatile Anaesthetic Agents Product and Services
2.10.4 Lunan Pharmaceutical Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Lunan Pharmaceutical Recent Developments/Updates
2.11 Hikma Pharmaceuticals
2.11.1 Hikma Pharmaceuticals Details
2.11.2 Hikma Pharmaceuticals Major Business
2.11.3 Hikma Pharmaceuticals Volatile Anaesthetic Agents Product and Services
2.11.4 Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Hikma Pharmaceuticals Recent Developments/Updates
2.12 HeBei YiPin Pharmaceutical
2.12.1 HeBei YiPin Pharmaceutical Details
2.12.2 HeBei YiPin Pharmaceutical Major Business
2.12.3 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product and Services
2.12.4 HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 HeBei YiPin Pharmaceutical Recent Developments/Updates
2.13 Dechra Pharmaceuticals
2.13.1 Dechra Pharmaceuticals Details
2.13.2 Dechra Pharmaceuticals Major Business
2.13.3 Dechra Pharmaceuticals Volatile Anaesthetic Agents Product and Services
2.13.4 Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Dechra Pharmaceuticals Recent Developments/Updates
2.14 Life Sciences
2.14.1 Life Sciences Details
2.14.2 Life Sciences Major Business
2.14.3 Life Sciences Volatile Anaesthetic Agents Product and Services
2.14.4 Life Sciences Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Life Sciences Recent Developments/Updates
2.15 Zhejiang AngLiKang Pharmaceutical
2.15.1 Zhejiang AngLiKang Pharmaceutical Details
2.15.2 Zhejiang AngLiKang Pharmaceutical Major Business
2.15.3 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product and Services
2.15.4 Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
2.16 Linde Healthcare
2.16.1 Linde Healthcare Details
2.16.2 Linde Healthcare Major Business
2.16.3 Linde Healthcare Volatile Anaesthetic Agents Product and Services
2.16.4 Linde Healthcare Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Linde Healthcare Recent Developments/Updates
2.17 Air Liquide
2.17.1 Air Liquide Details
2.17.2 Air Liquide Major Business
2.17.3 Air Liquide Volatile Anaesthetic Agents Product and Services
2.17.4 Air Liquide Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Air Liquide Recent Developments/Updates
2.18 Messer
2.18.1 Messer Details
2.18.2 Messer Major Business
2.18.3 Messer Volatile Anaesthetic Agents Product and Services
2.18.4 Messer Volatile Anaesthetic Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Messer Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: VOLATILE ANAESTHETIC AGENTS BY MANUFACTURER
3.1 Global Volatile Anaesthetic Agents Sales Quantity by Manufacturer (2021-2026)
3.2 Global Volatile Anaesthetic Agents Revenue by Manufacturer (2021-2026)
3.3 Global Volatile Anaesthetic Agents Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Volatile Anaesthetic Agents by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Volatile Anaesthetic Agents Manufacturer Market Share in 2025
3.4.3 Top 6 Volatile Anaesthetic Agents Manufacturer Market Share in 2025
3.5 Volatile Anaesthetic Agents Market: Overall Company Footprint Analysis
3.5.1 Volatile Anaesthetic Agents Market: Region Footprint
3.5.2 Volatile Anaesthetic Agents Market: Company Product Type Footprint
3.5.3 Volatile Anaesthetic Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Volatile Anaesthetic Agents Market Size by Region
4.1.1 Global Volatile Anaesthetic Agents Sales Quantity by Region (2021-2032)
4.1.2 Global Volatile Anaesthetic Agents Consumption Value by Region (2021-2032)
4.1.3 Global Volatile Anaesthetic Agents Average Price by Region (2021-2032)
4.2 North America Volatile Anaesthetic Agents Consumption Value (2021-2032)
4.3 Europe Volatile Anaesthetic Agents Consumption Value (2021-2032)
4.4 Asia-Pacific Volatile Anaesthetic Agents Consumption Value (2021-2032)
4.5 South America Volatile Anaesthetic Agents Consumption Value (2021-2032)
4.6 Middle East & Africa Volatile Anaesthetic Agents Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
5.2 Global Volatile Anaesthetic Agents Consumption Value by Type (2021-2032)
5.3 Global Volatile Anaesthetic Agents Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
6.2 Global Volatile Anaesthetic Agents Consumption Value by Application (2021-2032)
6.3 Global Volatile Anaesthetic Agents Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
7.2 North America Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
7.3 North America Volatile Anaesthetic Agents Market Size by Country
7.3.1 North America Volatile Anaesthetic Agents Sales Quantity by Country (2021-2032)
7.3.2 North America Volatile Anaesthetic Agents Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
8.2 Europe Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
8.3 Europe Volatile Anaesthetic Agents Market Size by Country
8.3.1 Europe Volatile Anaesthetic Agents Sales Quantity by Country (2021-2032)
8.3.2 Europe Volatile Anaesthetic Agents Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Volatile Anaesthetic Agents Market Size by Region
9.3.1 Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Volatile Anaesthetic Agents Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
10.2 South America Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
10.3 South America Volatile Anaesthetic Agents Market Size by Country
10.3.1 South America Volatile Anaesthetic Agents Sales Quantity by Country (2021-2032)
10.3.2 South America Volatile Anaesthetic Agents Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Volatile Anaesthetic Agents Market Size by Country
11.3.1 Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Volatile Anaesthetic Agents Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Volatile Anaesthetic Agents Market Drivers
12.2 Volatile Anaesthetic Agents Market Restraints
12.3 Volatile Anaesthetic Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Volatile Anaesthetic Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Volatile Anaesthetic Agents
13.3 Volatile Anaesthetic Agents Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Volatile Anaesthetic Agents Typical Distributors
14.3 Volatile Anaesthetic Agents Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Volatile Anaesthetic Agents Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Volatile Anaesthetic Agents Consumption Value by MAC, (USD Million), 2021 & 2025 & 2032
Table 3. Global Volatile Anaesthetic Agents Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Baxter Basic Information, Manufacturing Base and Competitors
Table 5. Baxter Major Business
Table 6. Baxter Volatile Anaesthetic Agents Product and Services
Table 7. Baxter Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Baxter Recent Developments/Updates
Table 9. AbbVie Basic Information, Manufacturing Base and Competitors
Table 10. AbbVie Major Business
Table 11. AbbVie Volatile Anaesthetic Agents Product and Services
Table 12. AbbVie Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. AbbVie Recent Developments/Updates
Table 14. Piramal Critical Care Basic Information, Manufacturing Base and Competitors
Table 15. Piramal Critical Care Major Business
Table 16. Piramal Critical Care Volatile Anaesthetic Agents Product and Services
Table 17. Piramal Critical Care Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Piramal Critical Care Recent Developments/Updates
Table 19. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 20. Fresenius Kabi Major Business
Table 21. Fresenius Kabi Volatile Anaesthetic Agents Product and Services
Table 22. Fresenius Kabi Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Fresenius Kabi Recent Developments/Updates
Table 24. Halocarbon Basic Information, Manufacturing Base and Competitors
Table 25. Halocarbon Major Business
Table 26. Halocarbon Volatile Anaesthetic Agents Product and Services
Table 27. Halocarbon Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Halocarbon Recent Developments/Updates
Table 29. Aspen Basic Information, Manufacturing Base and Competitors
Table 30. Aspen Major Business
Table 31. Aspen Volatile Anaesthetic Agents Product and Services
Table 32. Aspen Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Aspen Recent Developments/Updates
Table 34. Pfizer Basic Information, Manufacturing Base and Competitors
Table 35. Pfizer Major Business
Table 36. Pfizer Volatile Anaesthetic Agents Product and Services
Table 37. Pfizer Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Pfizer Recent Developments/Updates
Table 39. Maruishi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Maruishi Pharmaceutical Major Business
Table 41. Maruishi Pharmaceutical Volatile Anaesthetic Agents Product and Services
Table 42. Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Maruishi Pharmaceutical Recent Developments/Updates
Table 44. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 45. Jiangsu Hengrui Medicine Major Business
Table 46. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product and Services
Table 47. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 49. Lunan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 50. Lunan Pharmaceutical Major Business
Table 51. Lunan Pharmaceutical Volatile Anaesthetic Agents Product and Services
Table 52. Lunan Pharmaceutical Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Lunan Pharmaceutical Recent Developments/Updates
Table 54. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 55. Hikma Pharmaceuticals Major Business
Table 56. Hikma Pharmaceuticals Volatile Anaesthetic Agents Product and Services
Table 57. Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Hikma Pharmaceuticals Recent Developments/Updates
Table 59. HeBei YiPin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. HeBei YiPin Pharmaceutical Major Business
Table 61. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product and Services
Table 62. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. HeBei YiPin Pharmaceutical Recent Developments/Updates
Table 64. Dechra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 65. Dechra Pharmaceuticals Major Business
Table 66. Dechra Pharmaceuticals Volatile Anaesthetic Agents Product and Services
Table 67. Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Dechra Pharmaceuticals Recent Developments/Updates
Table 69. Life Sciences Basic Information, Manufacturing Base and Competitors
Table 70. Life Sciences Major Business
Table 71. Life Sciences Volatile Anaesthetic Agents Product and Services
Table 72. Life Sciences Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Life Sciences Recent Developments/Updates
Table 74. Zhejiang AngLiKang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 75. Zhejiang AngLiKang Pharmaceutical Major Business
Table 76. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product and Services
Table 77. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
Table 79. Linde Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Linde Healthcare Major Business
Table 81. Linde Healthcare Volatile Anaesthetic Agents Product and Services
Table 82. Linde Healthcare Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Linde Healthcare Recent Developments/Updates
Table 84. Air Liquide Basic Information, Manufacturing Base and Competitors
Table 85. Air Liquide Major Business
Table 86. Air Liquide Volatile Anaesthetic Agents Product and Services
Table 87. Air Liquide Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. Air Liquide Recent Developments/Updates
Table 89. Messer Basic Information, Manufacturing Base and Competitors
Table 90. Messer Major Business
Table 91. Messer Volatile Anaesthetic Agents Product and Services
Table 92. Messer Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 93. Messer Recent Developments/Updates
Table 94. Global Volatile Anaesthetic Agents Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 95. Global Volatile Anaesthetic Agents Revenue by Manufacturer (2021-2026) & (USD Million)
Table 96. Global Volatile Anaesthetic Agents Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 97. Market Position of Manufacturers in Volatile Anaesthetic Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 98. Head Office and Volatile Anaesthetic Agents Production Site of Key Manufacturer
Table 99. Volatile Anaesthetic Agents Market: Company Product Type Footprint
Table 100. Volatile Anaesthetic Agents Market: Company Product Application Footprint
Table 101. Volatile Anaesthetic Agents New Market Entrants and Barriers to Market Entry
Table 102. Volatile Anaesthetic Agents Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Volatile Anaesthetic Agents Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 104. Global Volatile Anaesthetic Agents Sales Quantity by Region (2021-2026) & (Tons)
Table 105. Global Volatile Anaesthetic Agents Sales Quantity by Region (2027-2032) & (Tons)
Table 106. Global Volatile Anaesthetic Agents Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Global Volatile Anaesthetic Agents Consumption Value by Region (2027-2032) & (USD Million)
Table 108. Global Volatile Anaesthetic Agents Average Price by Region (2021-2026) & (US$/kg)
Table 109. Global Volatile Anaesthetic Agents Average Price by Region (2027-2032) & (US$/kg)
Table 110. Global Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 111. Global Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 112. Global Volatile Anaesthetic Agents Consumption Value by Type (2021-2026) & (USD Million)
Table 113. Global Volatile Anaesthetic Agents Consumption Value by Type (2027-2032) & (USD Million)
Table 114. Global Volatile Anaesthetic Agents Average Price by Type (2021-2026) & (US$/kg)
Table 115. Global Volatile Anaesthetic Agents Average Price by Type (2027-2032) & (US$/kg)
Table 116. Global Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 117. Global Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 118. Global Volatile Anaesthetic Agents Consumption Value by Application (2021-2026) & (USD Million)
Table 119. Global Volatile Anaesthetic Agents Consumption Value by Application (2027-2032) & (USD Million)
Table 120. Global Volatile Anaesthetic Agents Average Price by Application (2021-2026) & (US$/kg)
Table 121. Global Volatile Anaesthetic Agents Average Price by Application (2027-2032) & (US$/kg)
Table 122. North America Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 123. North America Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 124. North America Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 125. North America Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 126. North America Volatile Anaesthetic Agents Sales Quantity by Country (2021-2026) & (Tons)
Table 127. North America Volatile Anaesthetic Agents Sales Quantity by Country (2027-2032) & (Tons)
Table 128. North America Volatile Anaesthetic Agents Consumption Value by Country (2021-2026) & (USD Million)
Table 129. North America Volatile Anaesthetic Agents Consumption Value by Country (2027-2032) & (USD Million)
Table 130. Europe Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 131. Europe Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 132. Europe Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 133. Europe Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 134. Europe Volatile Anaesthetic Agents Sales Quantity by Country (2021-2026) & (Tons)
Table 135. Europe Volatile Anaesthetic Agents Sales Quantity by Country (2027-2032) & (Tons)
Table 136. Europe Volatile Anaesthetic Agents Consumption Value by Country (2021-2026) & (USD Million)
Table 137. Europe Volatile Anaesthetic Agents Consumption Value by Country (2027-2032) & (USD Million)
Table 138. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 139. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 140. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 141. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 142. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Region (2021-2026) & (Tons)
Table 143. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Region (2027-2032) & (Tons)
Table 144. Asia-Pacific Volatile Anaesthetic Agents Consumption Value by Region (2021-2026) & (USD Million)
Table 145. Asia-Pacific Volatile Anaesthetic Agents Consumption Value by Region (2027-2032) & (USD Million)
Table 146. South America Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 147. South America Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 148. South America Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 149. South America Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 150. South America Volatile Anaesthetic Agents Sales Quantity by Country (2021-2026) & (Tons)
Table 151. South America Volatile Anaesthetic Agents Sales Quantity by Country (2027-2032) & (Tons)
Table 152. South America Volatile Anaesthetic Agents Consumption Value by Country (2021-2026) & (USD Million)
Table 153. South America Volatile Anaesthetic Agents Consumption Value by Country (2027-2032) & (USD Million)
Table 154. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 155. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 156. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 157. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 158. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Country (2021-2026) & (Tons)
Table 159. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Country (2027-2032) & (Tons)
Table 160. Middle East & Africa Volatile Anaesthetic Agents Consumption Value by Country (2021-2026) & (USD Million)
Table 161. Middle East & Africa Volatile Anaesthetic Agents Consumption Value by Country (2027-2032) & (USD Million)
Table 162. Volatile Anaesthetic Agents Raw Material
Table 163. Key Manufacturers of Volatile Anaesthetic Agents Raw Materials
Table 164. Volatile Anaesthetic Agents Typical Distributors
Table 165. Volatile Anaesthetic Agents Typical Customers
Table 1. Global Volatile Anaesthetic Agents Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Volatile Anaesthetic Agents Consumption Value by MAC, (USD Million), 2021 & 2025 & 2032
Table 3. Global Volatile Anaesthetic Agents Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Baxter Basic Information, Manufacturing Base and Competitors
Table 5. Baxter Major Business
Table 6. Baxter Volatile Anaesthetic Agents Product and Services
Table 7. Baxter Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Baxter Recent Developments/Updates
Table 9. AbbVie Basic Information, Manufacturing Base and Competitors
Table 10. AbbVie Major Business
Table 11. AbbVie Volatile Anaesthetic Agents Product and Services
Table 12. AbbVie Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. AbbVie Recent Developments/Updates
Table 14. Piramal Critical Care Basic Information, Manufacturing Base and Competitors
Table 15. Piramal Critical Care Major Business
Table 16. Piramal Critical Care Volatile Anaesthetic Agents Product and Services
Table 17. Piramal Critical Care Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Piramal Critical Care Recent Developments/Updates
Table 19. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 20. Fresenius Kabi Major Business
Table 21. Fresenius Kabi Volatile Anaesthetic Agents Product and Services
Table 22. Fresenius Kabi Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Fresenius Kabi Recent Developments/Updates
Table 24. Halocarbon Basic Information, Manufacturing Base and Competitors
Table 25. Halocarbon Major Business
Table 26. Halocarbon Volatile Anaesthetic Agents Product and Services
Table 27. Halocarbon Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Halocarbon Recent Developments/Updates
Table 29. Aspen Basic Information, Manufacturing Base and Competitors
Table 30. Aspen Major Business
Table 31. Aspen Volatile Anaesthetic Agents Product and Services
Table 32. Aspen Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Aspen Recent Developments/Updates
Table 34. Pfizer Basic Information, Manufacturing Base and Competitors
Table 35. Pfizer Major Business
Table 36. Pfizer Volatile Anaesthetic Agents Product and Services
Table 37. Pfizer Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Pfizer Recent Developments/Updates
Table 39. Maruishi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 40. Maruishi Pharmaceutical Major Business
Table 41. Maruishi Pharmaceutical Volatile Anaesthetic Agents Product and Services
Table 42. Maruishi Pharmaceutical Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Maruishi Pharmaceutical Recent Developments/Updates
Table 44. Jiangsu Hengrui Medicine Basic Information, Manufacturing Base and Competitors
Table 45. Jiangsu Hengrui Medicine Major Business
Table 46. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Product and Services
Table 47. Jiangsu Hengrui Medicine Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 49. Lunan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 50. Lunan Pharmaceutical Major Business
Table 51. Lunan Pharmaceutical Volatile Anaesthetic Agents Product and Services
Table 52. Lunan Pharmaceutical Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Lunan Pharmaceutical Recent Developments/Updates
Table 54. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 55. Hikma Pharmaceuticals Major Business
Table 56. Hikma Pharmaceuticals Volatile Anaesthetic Agents Product and Services
Table 57. Hikma Pharmaceuticals Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Hikma Pharmaceuticals Recent Developments/Updates
Table 59. HeBei YiPin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. HeBei YiPin Pharmaceutical Major Business
Table 61. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Product and Services
Table 62. HeBei YiPin Pharmaceutical Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. HeBei YiPin Pharmaceutical Recent Developments/Updates
Table 64. Dechra Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 65. Dechra Pharmaceuticals Major Business
Table 66. Dechra Pharmaceuticals Volatile Anaesthetic Agents Product and Services
Table 67. Dechra Pharmaceuticals Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 68. Dechra Pharmaceuticals Recent Developments/Updates
Table 69. Life Sciences Basic Information, Manufacturing Base and Competitors
Table 70. Life Sciences Major Business
Table 71. Life Sciences Volatile Anaesthetic Agents Product and Services
Table 72. Life Sciences Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 73. Life Sciences Recent Developments/Updates
Table 74. Zhejiang AngLiKang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 75. Zhejiang AngLiKang Pharmaceutical Major Business
Table 76. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Product and Services
Table 77. Zhejiang AngLiKang Pharmaceutical Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 78. Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
Table 79. Linde Healthcare Basic Information, Manufacturing Base and Competitors
Table 80. Linde Healthcare Major Business
Table 81. Linde Healthcare Volatile Anaesthetic Agents Product and Services
Table 82. Linde Healthcare Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 83. Linde Healthcare Recent Developments/Updates
Table 84. Air Liquide Basic Information, Manufacturing Base and Competitors
Table 85. Air Liquide Major Business
Table 86. Air Liquide Volatile Anaesthetic Agents Product and Services
Table 87. Air Liquide Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 88. Air Liquide Recent Developments/Updates
Table 89. Messer Basic Information, Manufacturing Base and Competitors
Table 90. Messer Major Business
Table 91. Messer Volatile Anaesthetic Agents Product and Services
Table 92. Messer Volatile Anaesthetic Agents Sales Quantity (Tons), Average Price (US$/kg), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 93. Messer Recent Developments/Updates
Table 94. Global Volatile Anaesthetic Agents Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 95. Global Volatile Anaesthetic Agents Revenue by Manufacturer (2021-2026) & (USD Million)
Table 96. Global Volatile Anaesthetic Agents Average Price by Manufacturer (2021-2026) & (US$/kg)
Table 97. Market Position of Manufacturers in Volatile Anaesthetic Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 98. Head Office and Volatile Anaesthetic Agents Production Site of Key Manufacturer
Table 99. Volatile Anaesthetic Agents Market: Company Product Type Footprint
Table 100. Volatile Anaesthetic Agents Market: Company Product Application Footprint
Table 101. Volatile Anaesthetic Agents New Market Entrants and Barriers to Market Entry
Table 102. Volatile Anaesthetic Agents Mergers, Acquisition, Agreements, and Collaborations
Table 103. Global Volatile Anaesthetic Agents Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 104. Global Volatile Anaesthetic Agents Sales Quantity by Region (2021-2026) & (Tons)
Table 105. Global Volatile Anaesthetic Agents Sales Quantity by Region (2027-2032) & (Tons)
Table 106. Global Volatile Anaesthetic Agents Consumption Value by Region (2021-2026) & (USD Million)
Table 107. Global Volatile Anaesthetic Agents Consumption Value by Region (2027-2032) & (USD Million)
Table 108. Global Volatile Anaesthetic Agents Average Price by Region (2021-2026) & (US$/kg)
Table 109. Global Volatile Anaesthetic Agents Average Price by Region (2027-2032) & (US$/kg)
Table 110. Global Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 111. Global Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 112. Global Volatile Anaesthetic Agents Consumption Value by Type (2021-2026) & (USD Million)
Table 113. Global Volatile Anaesthetic Agents Consumption Value by Type (2027-2032) & (USD Million)
Table 114. Global Volatile Anaesthetic Agents Average Price by Type (2021-2026) & (US$/kg)
Table 115. Global Volatile Anaesthetic Agents Average Price by Type (2027-2032) & (US$/kg)
Table 116. Global Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 117. Global Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 118. Global Volatile Anaesthetic Agents Consumption Value by Application (2021-2026) & (USD Million)
Table 119. Global Volatile Anaesthetic Agents Consumption Value by Application (2027-2032) & (USD Million)
Table 120. Global Volatile Anaesthetic Agents Average Price by Application (2021-2026) & (US$/kg)
Table 121. Global Volatile Anaesthetic Agents Average Price by Application (2027-2032) & (US$/kg)
Table 122. North America Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 123. North America Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 124. North America Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 125. North America Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 126. North America Volatile Anaesthetic Agents Sales Quantity by Country (2021-2026) & (Tons)
Table 127. North America Volatile Anaesthetic Agents Sales Quantity by Country (2027-2032) & (Tons)
Table 128. North America Volatile Anaesthetic Agents Consumption Value by Country (2021-2026) & (USD Million)
Table 129. North America Volatile Anaesthetic Agents Consumption Value by Country (2027-2032) & (USD Million)
Table 130. Europe Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 131. Europe Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 132. Europe Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 133. Europe Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 134. Europe Volatile Anaesthetic Agents Sales Quantity by Country (2021-2026) & (Tons)
Table 135. Europe Volatile Anaesthetic Agents Sales Quantity by Country (2027-2032) & (Tons)
Table 136. Europe Volatile Anaesthetic Agents Consumption Value by Country (2021-2026) & (USD Million)
Table 137. Europe Volatile Anaesthetic Agents Consumption Value by Country (2027-2032) & (USD Million)
Table 138. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 139. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 140. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 141. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 142. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Region (2021-2026) & (Tons)
Table 143. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity by Region (2027-2032) & (Tons)
Table 144. Asia-Pacific Volatile Anaesthetic Agents Consumption Value by Region (2021-2026) & (USD Million)
Table 145. Asia-Pacific Volatile Anaesthetic Agents Consumption Value by Region (2027-2032) & (USD Million)
Table 146. South America Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 147. South America Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 148. South America Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 149. South America Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 150. South America Volatile Anaesthetic Agents Sales Quantity by Country (2021-2026) & (Tons)
Table 151. South America Volatile Anaesthetic Agents Sales Quantity by Country (2027-2032) & (Tons)
Table 152. South America Volatile Anaesthetic Agents Consumption Value by Country (2021-2026) & (USD Million)
Table 153. South America Volatile Anaesthetic Agents Consumption Value by Country (2027-2032) & (USD Million)
Table 154. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Type (2021-2026) & (Tons)
Table 155. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Type (2027-2032) & (Tons)
Table 156. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Application (2021-2026) & (Tons)
Table 157. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Application (2027-2032) & (Tons)
Table 158. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Country (2021-2026) & (Tons)
Table 159. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity by Country (2027-2032) & (Tons)
Table 160. Middle East & Africa Volatile Anaesthetic Agents Consumption Value by Country (2021-2026) & (USD Million)
Table 161. Middle East & Africa Volatile Anaesthetic Agents Consumption Value by Country (2027-2032) & (USD Million)
Table 162. Volatile Anaesthetic Agents Raw Material
Table 163. Key Manufacturers of Volatile Anaesthetic Agents Raw Materials
Table 164. Volatile Anaesthetic Agents Typical Distributors
Table 165. Volatile Anaesthetic Agents Typical Customers
LIST OF FIGURES
Figure 1. Volatile Anaesthetic Agents Picture
Figure 2. Global Volatile Anaesthetic Agents Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Volatile Anaesthetic Agents Revenue Market Share by Type in 2025
Figure 4. Heptafluoroane Examples
Figure 5. Desflurane Examples
Figure 6. Isoflurane Examples
Figure 7. Others Examples
Figure 8. Global Volatile Anaesthetic Agents Revenue by MAC, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Volatile Anaesthetic Agents Revenue Market Share by MAC in 2025
Figure 10. Below 3% Examples
Figure 11. Above 3% Examples
Figure 12. Global Volatile Anaesthetic Agents Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Volatile Anaesthetic Agents Revenue Market Share by Application in 2025
Figure 14. Human Use Examples
Figure 15. Animal Use Examples
Figure 16. Global Volatile Anaesthetic Agents Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global Volatile Anaesthetic Agents Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global Volatile Anaesthetic Agents Sales Quantity (2021-2032) & (Tons)
Figure 19. Global Volatile Anaesthetic Agents Price (2021-2032) & (US$/kg)
Figure 20. Global Volatile Anaesthetic Agents Sales Quantity Market Share by Manufacturer in 2025
Figure 21. Global Volatile Anaesthetic Agents Revenue Market Share by Manufacturer in 2025
Figure 22. Producer Shipments of Volatile Anaesthetic Agents by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 23. Top 3 Volatile Anaesthetic Agents Manufacturer (Revenue) Market Share in 2025
Figure 24. Top 6 Volatile Anaesthetic Agents Manufacturer (Revenue) Market Share in 2025
Figure 25. Global Volatile Anaesthetic Agents Sales Quantity Market Share by Region (2021-2032)
Figure 26. Global Volatile Anaesthetic Agents Consumption Value Market Share by Region (2021-2032)
Figure 27. North America Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 32. Global Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 33. Global Volatile Anaesthetic Agents Consumption Value Market Share by Type (2021-2032)
Figure 34. Global Volatile Anaesthetic Agents Average Price by Type (2021-2032) & (US$/kg)
Figure 35. Global Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 36. Global Volatile Anaesthetic Agents Revenue Market Share by Application (2021-2032)
Figure 37. Global Volatile Anaesthetic Agents Average Price by Application (2021-2032) & (US$/kg)
Figure 38. North America Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 39. North America Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 40. North America Volatile Anaesthetic Agents Sales Quantity Market Share by Country (2021-2032)
Figure 41. North America Volatile Anaesthetic Agents Consumption Value Market Share by Country (2021-2032)
Figure 42. United States Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 46. Europe Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 47. Europe Volatile Anaesthetic Agents Sales Quantity Market Share by Country (2021-2032)
Figure 48. Europe Volatile Anaesthetic Agents Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 50. France Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity Market Share by Region (2021-2032)
Figure 57. Asia-Pacific Volatile Anaesthetic Agents Consumption Value Market Share by Region (2021-2032)
Figure 58. China Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 61. India Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 65. South America Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 66. South America Volatile Anaesthetic Agents Sales Quantity Market Share by Country (2021-2032)
Figure 67. South America Volatile Anaesthetic Agents Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity Market Share by Country (2021-2032)
Figure 73. Middle East & Africa Volatile Anaesthetic Agents Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 75. Egypt Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 77. South Africa Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 78. Volatile Anaesthetic Agents Market Drivers
Figure 79. Volatile Anaesthetic Agents Market Restraints
Figure 80. Volatile Anaesthetic Agents Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Volatile Anaesthetic Agents in 2025
Figure 83. Manufacturing Process Analysis of Volatile Anaesthetic Agents
Figure 84. Volatile Anaesthetic Agents Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
Figure 1. Volatile Anaesthetic Agents Picture
Figure 2. Global Volatile Anaesthetic Agents Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Volatile Anaesthetic Agents Revenue Market Share by Type in 2025
Figure 4. Heptafluoroane Examples
Figure 5. Desflurane Examples
Figure 6. Isoflurane Examples
Figure 7. Others Examples
Figure 8. Global Volatile Anaesthetic Agents Revenue by MAC, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Volatile Anaesthetic Agents Revenue Market Share by MAC in 2025
Figure 10. Below 3% Examples
Figure 11. Above 3% Examples
Figure 12. Global Volatile Anaesthetic Agents Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 13. Global Volatile Anaesthetic Agents Revenue Market Share by Application in 2025
Figure 14. Human Use Examples
Figure 15. Animal Use Examples
Figure 16. Global Volatile Anaesthetic Agents Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 17. Global Volatile Anaesthetic Agents Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 18. Global Volatile Anaesthetic Agents Sales Quantity (2021-2032) & (Tons)
Figure 19. Global Volatile Anaesthetic Agents Price (2021-2032) & (US$/kg)
Figure 20. Global Volatile Anaesthetic Agents Sales Quantity Market Share by Manufacturer in 2025
Figure 21. Global Volatile Anaesthetic Agents Revenue Market Share by Manufacturer in 2025
Figure 22. Producer Shipments of Volatile Anaesthetic Agents by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 23. Top 3 Volatile Anaesthetic Agents Manufacturer (Revenue) Market Share in 2025
Figure 24. Top 6 Volatile Anaesthetic Agents Manufacturer (Revenue) Market Share in 2025
Figure 25. Global Volatile Anaesthetic Agents Sales Quantity Market Share by Region (2021-2032)
Figure 26. Global Volatile Anaesthetic Agents Consumption Value Market Share by Region (2021-2032)
Figure 27. North America Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 28. Europe Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 29. Asia-Pacific Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 30. South America Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 31. Middle East & Africa Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 32. Global Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 33. Global Volatile Anaesthetic Agents Consumption Value Market Share by Type (2021-2032)
Figure 34. Global Volatile Anaesthetic Agents Average Price by Type (2021-2032) & (US$/kg)
Figure 35. Global Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 36. Global Volatile Anaesthetic Agents Revenue Market Share by Application (2021-2032)
Figure 37. Global Volatile Anaesthetic Agents Average Price by Application (2021-2032) & (US$/kg)
Figure 38. North America Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 39. North America Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 40. North America Volatile Anaesthetic Agents Sales Quantity Market Share by Country (2021-2032)
Figure 41. North America Volatile Anaesthetic Agents Consumption Value Market Share by Country (2021-2032)
Figure 42. United States Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 46. Europe Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 47. Europe Volatile Anaesthetic Agents Sales Quantity Market Share by Country (2021-2032)
Figure 48. Europe Volatile Anaesthetic Agents Consumption Value Market Share by Country (2021-2032)
Figure 49. Germany Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 50. France Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 51. United Kingdom Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 52. Russia Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 53. Italy Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 55. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 56. Asia-Pacific Volatile Anaesthetic Agents Sales Quantity Market Share by Region (2021-2032)
Figure 57. Asia-Pacific Volatile Anaesthetic Agents Consumption Value Market Share by Region (2021-2032)
Figure 58. China Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 59. Japan Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 60. South Korea Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 61. India Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 62. Southeast Asia Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 63. Australia Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 64. South America Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 65. South America Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 66. South America Volatile Anaesthetic Agents Sales Quantity Market Share by Country (2021-2032)
Figure 67. South America Volatile Anaesthetic Agents Consumption Value Market Share by Country (2021-2032)
Figure 68. Brazil Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 69. Argentina Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 70. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity Market Share by Type (2021-2032)
Figure 71. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity Market Share by Application (2021-2032)
Figure 72. Middle East & Africa Volatile Anaesthetic Agents Sales Quantity Market Share by Country (2021-2032)
Figure 73. Middle East & Africa Volatile Anaesthetic Agents Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 75. Egypt Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 77. South Africa Volatile Anaesthetic Agents Consumption Value (2021-2032) & (USD Million)
Figure 78. Volatile Anaesthetic Agents Market Drivers
Figure 79. Volatile Anaesthetic Agents Market Restraints
Figure 80. Volatile Anaesthetic Agents Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Manufacturing Cost Structure Analysis of Volatile Anaesthetic Agents in 2025
Figure 83. Manufacturing Process Analysis of Volatile Anaesthetic Agents
Figure 84. Volatile Anaesthetic Agents Industrial Chain
Figure 85. Sales Channel: Direct to End-User vs Distributors
Figure 86. Direct Channel Pros & Cons
Figure 87. Indirect Channel Pros & Cons
Figure 88. Methodology
Figure 89. Research Process and Data Source
